Physician profile
Tin C Tran
NPI 1518126879
$15,781.89
in general payments reported to CMS, 2019-2025
29 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $56.52 · 2021: $196 · 2022: $474 · 2023: $702 · 2024: $869 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,290.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,495.53 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $467.94 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce, Seamguard |
| Abbvie INC. | $278.47 | 2022-2025 | Creon, Linzess |
| Novo Nordisk INC | $216.70 | 2019-2025 | Wegovy |
| Davol INC. | $186.77 | 2022 | |
| Phathom Pharmaceuticals, INC. | $171.65 | 2024-2025 | Voquezna |
| Medtronic, INC. | $154.79 | 2022-2025 | Signia, Endo Gia Ultra |
| Lilly USA, LLC | $92.98 | 2023-2025 | Zepbound |
| Teleflex LLC | $86.86 | 2019-2023 | Titan Sgs Standard Gastric Stapler |
| Baxter Healthcare | $86.58 | 2021-2024 | Perclot |
| Acacia Pharma INC | $81.73 | 2021-2022 | |
| Heron Therapeutics, INC. | $56.75 | 2022-2023 | Zynrelef |
| Myriad Genetic Laboratories, INC. | $46.27 | 2021-2023 | Myrisk |
| Vertex Pharmaceuticals Incorporated | $45.96 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $33.81 | 2019-2024 | Bridion |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirius Medical Systems | $31.71 | 2023 | Pintuition |
| Reprise Biomedical, INC. | $27.15 | 2025 | Miro3d |
| Solventum Corporation | $26.08 | 2024 | Prevena |
| Regeneron Healthcare Solutions, INC. | $25.99 | 2020 | |
| Biotissue Holdings INC. | $21.69 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $21.36 | 2019 | |
| Kci USA, INC. | $21.17 | 2023 | Prevena |
| Ethicon US, LLC | $18.31 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.23 | 2025 | Exparel |
| Currax Pharmaceuticals LLC | $17.21 | 2025 | Contrave |
| Ambu INC. | $14.39 | 2023 | |
| Becton, Dickinson and Company | $13.79 | 2022 | |
| Tela Bio, INC. | $12.22 | 2020 | |
| Covidien LP | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tin Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.